Search results
Alison Lawton (born May 29, 1970) is a Canadian social venture philanthropist, social advocate, and business investor.
View Alison Lawton’s profile on LinkedIn, a professional community of 1 billion members. Seasoned Biotech Executive with experience as CEO, Chair and independent director of…
- Dianthus Therapeutics, Inc.
Alison Lawton is an executive leader with more than 30 years of biopharma experience, having most recently served as president and CEO of Kaleido Biosciences. Previously, she served as chief operating officer (COO) of Aura Biosciences and OvaScience.
ALISON LAWTON - PRESIDENT. Alison founded Mindset Venture Group in 1997 (formerly known as Winfield Venture Group Ltd.) and has a track record of identifying successful scalable businesses. Alison began her career in private equity sales in the areas of syndicated software, film, television, and real estate.
Jun 25, 2024 · Alison Lawton is an executive leader with more than 30 years of experience in biopharma. She served as President and Chief Executive Officer of Kaleido Biosciences, Inc. from August 2018 to June 2020, and served as President and Chief Operating Officer from December 2017 to August 2018.
Alison Lawton most recently served as Kaleido’s Chief Executive Officer, President and as a member of the Board of Directors since August 2018, after initially joining the company as President and Chief Operating Officer in December 2017. Ms.
Dec 17, 2020 · Lawton currently serves as independent director for X4 Pharmaceuticals and ProQR Therapeutics and has served on the Boards of Directors of Verastem, CoLucid until its acquisition by Eli Lilly, and Cubist Pharmaceuticals until its acquisition by Merck & Co.
